Contineum Therapeutics In... (CTNM)
Contineum Therapeutics Class A Common Stock Max Pain By Strike
CTNM trades at $7.36, 194.4% above the near-term max pain of $2.5 expiring Sep 19, 2025 (34 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($2.5-$5), reflecting growing call interest at higher strikes. Key magnetic zone at 3 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Contineum Therapeutics Class A Common Stock Max Pain By Expiry
Max pain for CTNM shows an upward trend from 2.5 to 5, suggesting bullish positioning in longer-dated options. The 80% spread signals divergent expectations across timeframes. Most levels below 7.36 may cap rallies. Strong magnetic level at 3 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 2.5 | -4.86 (-66.03%) |
| Oct 17, 2025 | 5 | -2.36 (-32.07%) |
| Jan 16, 2026 | 2.5 | -4.86 (-66.03%) |
| Apr 17, 2026 | 2.5 | -4.86 (-66.03%) |